Initial Statement of Beneficial Ownership (3)
August 26 2013 - 7:22AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Yang Gang CBPO
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/16/2013
|
3. Issuer Name
and
Ticker or Trading Symbol
China Biologic Products, Inc. [CBPO]
|
(Last)
(First)
(Middle)
C/O CBPO, 18F, JIALONG INT'L TOWER,, 19 CHAOYANG PARK RD.
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
Corporate Vice President /
|
(Street)
BEIJING, F4 100125
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Restricted Stock
(1)
|
5000
|
D
|
|
Restricted Stock
(2)
|
20000
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (right to buy)
(3)
|
(3)
|
7/11/2020
|
Common Stock
|
40000
(3)
|
$12.26
|
D
|
|
Stock Option (right to buy)
(4)
|
(4)
|
8/31/2022
|
Common Stock
|
15000
(4)
|
$9.85
|
D
|
|
Explanation of Responses:
|
(
1)
|
Represents the grant of restricted stock to the Reporting Person, under the Issuer's 2008 equity incentive plan (the "2008 Plan"), pursuant to a restricted stock grant agreement dated August 31, 2012 (the "2012 Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 48-month period in four equal portions, with an initial vesting date on September 1, 2013, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2012 Restricted Stock Agreement) from August 31, 2012 until the date such vesting occurs.
|
(
2)
|
Represents the grant of restricted stock to the Reporting Person under the 2008 plan, pursuant to a restricted stock award agreement dated August 16, 2013 (the "2013 Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 48-month period in four equal portions, with an initial vesting date on August 16, 2014, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2013 Restricted Stock Agreement) from August 16, 2013 until the date such vesting occurs.
|
(
3)
|
Represents ten year non-qualified stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the 2008 Plan, pursuant to a stock option agreement dated July 11, 2010 (the "2010 Stock Option Agreement"). The options are fully vested and exercisable as of the reporting date.
|
(
4)
|
Represents ten year non-qualified stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the 2008 Plan, pursuant to a stock option agreement dated August 31, 2012 (the "2012 Stock Option Agreement"). The options will vest annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013, provided that the Reporting Person has been continuously a Service Provider (as defined in the 2012 Stock Option Agreement) from August 31, 2012 until the date such vesting occurs.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Yang Gang CBPO
C/O CBPO, 18F, JIALONG INT'L TOWER,
19 CHAOYANG PARK RD.
BEIJING, F4 100125
|
|
|
Corporate Vice President
|
|
Signatures
|
/s/Yang, Gang CBPO
|
|
8/26/2013
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024